<VariationArchive VariationID="574154" VariationName="NM_004168.4(SDHA):c.46_52dup (p.Leu18fs)" VariationType="Duplication" Accession="VCV000574154" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-05-08" DateCreated="2018-10-10" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="560293" VariationID="574154">
      <GeneList>
        <Gene Symbol="SDHA" FullName="succinate dehydrogenase complex flavoprotein subunit A" GeneID="6389" HGNC_ID="HGNC:10680" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5p15.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="218320" stop="268746" display_start="218320" display_stop="268746" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="218355" stop="256814" display_start="218355" display_stop="256814" Strand="+" />
          </Location>
          <OMIM>600857</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004168.4(SDHA):c.46_52dup (p.Leu18fs)</Name>
      <CanonicalSPDI>NC_000005.10:218395:GGCGCCTGGCGC:GGCGCCTGGCGCCTGGCGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5p15.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="218395" stop="218396" display_start="218395" display_stop="218396" variantLength="7" positionVCF="218395" referenceAlleleVCF="C" alternateAlleleVCF="CGGCGCCT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="218510" stop="218511" display_start="218510" display_stop="218511" variantLength="7" positionVCF="218510" referenceAlleleVCF="C" alternateAlleleVCF="CGGCGCCT" />
      </Location>
      <ProteinChange>L18fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.218401_218407dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.218401_218407dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.218516_218522dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.218516_218522dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012339.1" sequenceAccession="NG_012339" sequenceVersion="1" change="g.5161_5167dup">
            <Expression>NG_012339.1:g.5161_5167dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033064.1" sequenceAccession="NG_033064" sequenceVersion="1" change="g.4781_4787dup">
            <Expression>NG_033064.1:g.4781_4787dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001294332.2" sequenceAccession="NM_001294332" sequenceVersion="2" change="c.46_52dup">
            <Expression>NM_001294332.2:c.46_52dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001281261.1" sequenceAccession="NP_001281261" sequenceVersion="1" change="p.Leu18fs">
            <Expression>NP_001281261.1:p.Leu18fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330758.2" sequenceAccession="NM_001330758" sequenceVersion="2" change="c.46_52dup">
            <Expression>NM_001330758.2:c.46_52dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317687.1" sequenceAccession="NP_001317687" sequenceVersion="1" change="p.Leu18fs">
            <Expression>NP_001317687.1:p.Leu18fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004168.4" sequenceAccession="NM_004168" sequenceVersion="4" change="c.46_52dup" MANESelect="true">
            <Expression>NM_004168.4:c.46_52dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004159.2" sequenceAccession="NP_004159" sequenceVersion="2" change="p.Leu18fs">
            <Expression>NP_004159.2:p.Leu18fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_315" sequenceAccession="LRG_315">
            <Expression>LRG_315:g.5161_5167dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_315t1" sequenceAccession="LRG_315t1">
            <Expression>LRG_315t1:c.46_52dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_315p1" sequenceAccession="LRG_315p1" change="p.Leu18fs">
            <Expression>LRG_315p1:p.Leu18fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004168.3" sequenceAccession="NM_004168" sequenceVersion="3" change="c.46_52dupCTGGCGC">
            <Expression>NM_004168.3:c.46_52dupCTGGCGC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004168.2" sequenceAccession="NM_004168" sequenceVersion="2" change="c.46_52dup">
            <Expression>NM_004168.2:c.46_52dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1560980939" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004168.4(SDHA):c.46_52dup (p.Leu18fs) AND multiple conditions" Accession="RCV000696009" Version="4">
        <ClassifiedConditionList TraitSetID="23694">
          <ClassifiedCondition DB="MedGen" ID="C5700310">Mitochondrial complex II deficiency, nuclear type 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3279992">Paragangliomas 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004168.4(SDHA):c.46_52dup (p.Leu18fs) AND not provided" Accession="RCV003128647" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-16" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004168.4(SDHA):c.46_52dup (p.Leu18fs) AND Paragangliomas 5" Accession="RCV004026357" Version="1">
        <ClassifiedConditionList TraitSetID="7580">
          <ClassifiedCondition DB="MedGen" ID="C3279992">Paragangliomas 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-07" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-10-10" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22974104</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24781757</ID>
        </Citation>
        <DescriptionHistory Dated="2023-03-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="23694" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16481" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Paragangliomas 5</ElementValue>
                <XRef ID="Paragangliomas+5/9075" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013602" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPGL5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PGL5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15763" />
                <XRef ID="15763" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas cause catecholamine excess; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base and neck (referred to as head and neck PGL [HNPGL]) and sometimes in the upper mediastinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically lead to catecholamine excess. Symptoms of PGL/PCC result from either mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for developing metastatic disease is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas.</Attribute>
                <XRef ID="NBK1548" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301715</ID>
                <ID Source="BookShelf">NBK1548</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2014">
                <ID Source="PubMed">24893135</ID>
              </Citation>
              <XRef ID="29072" DB="Orphanet" />
              <XRef ID="C3279992" DB="MedGen" />
              <XRef ID="MONDO:0013602" DB="MONDO" />
              <XRef Type="MIM" ID="614165" DB="OMIM" />
            </Trait>
            <Trait ID="5546" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mitochondrial complex II deficiency</ElementValue>
                <XRef ID="Mitochondrial+complex+II+deficiency/4824" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mitochondrial complex II deficiency, nuclear type 1</ElementValue>
                <XRef ID="MONDO:0100294" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Complex 2 mitochondrial respiratory chain deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Succinate CoQ reductase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5053" />
                <XRef ID="5053" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3208" DB="Orphanet" />
              <XRef ID="C5700310" DB="MedGen" />
              <XRef ID="MONDO:0100294" DB="MONDO" />
              <XRef Type="MIM" ID="252011" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7580" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16481" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Paragangliomas 5</ElementValue>
                <XRef ID="Paragangliomas+5/9075" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013602" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPGL5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PGL5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15763" />
                <XRef ID="15763" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas cause catecholamine excess; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base and neck (referred to as head and neck PGL [HNPGL]) and sometimes in the upper mediastinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically lead to catecholamine excess. Symptoms of PGL/PCC result from either mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for developing metastatic disease is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas.</Attribute>
                <XRef ID="NBK1548" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301715</ID>
                <ID Source="BookShelf">NBK1548</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2014">
                <ID Source="PubMed">24893135</ID>
              </Citation>
              <XRef ID="29072" DB="Orphanet" />
              <XRef ID="C3279992" DB="MedGen" />
              <XRef ID="MONDO:0013602" DB="MONDO" />
              <XRef Type="MIM" ID="614165" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7110657" SubmissionDate="2023-03-01" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="GDXSV:261549" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003805382" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHA" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:4906207</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004168.2:c.46_52dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_166_20230301054205</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1596345" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="1114883|MedGen:C3279992;C1855008" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000824550" DateUpdated="2024-02-28" DateCreated="2018-10-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22974104</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24781757</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu18Profs*23) in the SDHA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SDHA are known to be pathogenic (PMID: 22974104, 24781757). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SDHA-related conditions. ClinVar contains an entry for this variant (Variation ID: 574154). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.218510_218511insGGCGCCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3279992" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1855008" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9142395" SubmissionDate="2024-04-22" DateLastUpdated="2024-05-01" DateCreated="2024-05-01">
        <ClinVarSubmissionID localKey="102369605|OMIM:614165" />
        <ClinVarAccession Accession="SCV004933820" DateUpdated="2024-05-01" DateCreated="2024-05-01" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="5" alternateAllele="CCTGGCGC" referenceAllele="C" start="218522" stop="218522" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">102369605</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614165" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14395420</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9142395" TraitType="Disease" MappingType="XRef" MappingValue="614165" MappingRef="OMIM">
        <MedGen CUI="C3279992" Name="Paragangliomas 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1596345" TraitType="Disease" MappingType="XRef" MappingValue="C3279992" MappingRef="MedGen">
        <MedGen CUI="C3279992" Name="Paragangliomas 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7110657" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1596345" TraitType="Disease" MappingType="XRef" MappingValue="C1855008" MappingRef="MedGen">
        <MedGen CUI="C5700310" Name="Mitochondrial complex II deficiency, nuclear type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

